Biotage AB Profile

USD 0.00  0.00%

Biotage AB Summary

Biotage AB (BITGF) is traded on OTC Market in USA. It is located in Box 8 and employs 397 people. The company currently falls under 'Small-Cap' category with current market capitalization of 771.56 M. Biotage AB has 64.71 M outstanding shares. BIOTAGE AB has accumulated about 20.12 M in cash with 20 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.31.
Check Biotage AB Probability Of Bankruptcy

Target Price Odds Analysis

Odds Below 10.1HorizonTargetOdds Above 10.1
?%30 days 10.10 ?%
Based on normal probability distribution, the odds of Biotage AB to move above current price in 30 days from now is about 0.0% (This Biotage AB probability density function shows the probability of Biotage AB Stock to fall within a particular range of prices over 30 days) .

Key Fundamentals

Biotage AB Against Markets

Current Ratings

Biotage AB 30 Days Performance Scores
Risk Adjusted
Performance Score (0 to 100)
Chance of
Financial Distress (0 to 100%)
Equity ratings for Biotage AB are calculated dynamically based on Macroaxis scoring framework. Click here to learn more
Biotage AB , a life science company, provides solutions, knowledge, and experience in the areas of analytical chemistry, medicinal chemistry, peptide synthesis, separation, and purification in the United States, Europe, Japan, China, and internationally. It sells its products to pharmaceutical and biotechnical companies, contract research and manufacturing organizations, and academic institutions and commercial, hospitalbio-analytical, and forensic laboratories, as well as laboratories within food and environmental analysis. Biotage AB operates under Medical Instruments Supplies classification in USA and traded on OTC Market. It employs 7 people. more
NameBiotage AB
President and CEOTorben JoergensenView All
Macroaxis Advice
InstrumentUSA Stock View All
Business AddressBox 8
ExchangeOTC Market
Contact Number46 18 56 59 00
CurrencyUSD - US Dollar

Diversify with Biotage AB

Build Optimal Portfolios
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add Biotage AB to your portfolio


Biotage AB Corporate Directors
Karolina Lawitz Member of the Board of Directors
NilsOlof Bjork Director, Ph.D
Yvonne Martensson Director
Check also Trending Equities. Please also try Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.